Kairos Archives - Kairos Ventures

CytoDel

By: Charissa On: December 8, 2022 In:

Stoicheia

By: Charissa On: April 8, 2021 In:

Stoicheia is revolutionizing the way we discover new materials, especially materials fit for specific tasks and able to meet...

Vivodyne

By: Charissa On: April 8, 2021 In:

Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug...

Actinia

By: Charissa On: February 26, 2021 In:

Actinia develops radiation detection solutions for medical imaging, nuclear energy applications, and non-proliferation of illicit radioactive materials.

Novosteo

By: Charissa On: November 23, 2020 In:

Novosteo Inc. is developing novel therapeutics for the treatment of bone injury and diseases that impact patient mobility and...

Siege Pharmaceuticals

By: Charissa On: November 20, 2020 In:

Siege Pharmaceuticals is developing new cancer drugs based on a naturally-occurring molecule that starves cancer cells to death.

NVasc

By: Charissa On: November 20, 2020 In:

NVasc, Inc. is an early-stage ophthalmology company focused on the treatment of ischemic eye diseases, such as age-related macular...

AetherTouch

By: Charissa On: November 20, 2020 In:

AetherTouch is revolutionizing the user interface for today’s mobile electronics by using acoustic waves to allow you to control...

FastDetect

By: Charissa On: September 22, 2020 In:

The world’s first COVID-19 testing device using RT-PCR, the gold standard of testing, to provide high accuracy results in...

PteroDynamics

By: Charissa On: August 13, 2020 In:

PteroDynamics has developed the world’s best drone by cargo carrying efficiency, a VTOL (vertical takeoff and landing) aircraft that...

CytoDel

Stoicheia

Vivodyne

Actinia

Novosteo

Siege Pharmaceuticals

NVasc

AetherTouch

FastDetect

PteroDynamics

Subscribe to Kairos News

Recent Posts

Categories